FLC
Asset Logo

Fluence Corporation Limited

πŸ‡¦πŸ‡Ί ASX

πŸ”‹ UTILITIES

Compare
Add to watchlist
πŸ‘‘ Overview

πŸ“ˆ Performance

πŸ’΅ Cost

πŸ€“ Advanced

πŸ‘¨β€πŸ‘©β€πŸ‘§β€πŸ‘¦ Community

πŸ“ˆ

-15.87%
Annual Growth

5 years average annual growth

πŸ’΅

$ 500
Minimum Order

Due to regulatory requirements

🌏

3
Pearlers Invested

Since January 2020

πŸ‘‘ Overview

Key information
πŸ”Ž Fund Overview

Fluence Corp. Ltd. engages in the provision of fast-to-deploy, decentralized and smart water, and wastewater treatment solutions. The firm is engaged in wastewater treatment and reuse, high-strength wastewater treatment, wastewater-to-energy, industrial and drinking water markets, with its pre-engineered, standardized smart products solutions (SPS), including Aspiral, NIROBOX, SUBRE and Nitro. Its segments include Decentralized Municipal Water and Wastewater treatment (DMWW), Specialized Industrial Water solutions (SIW), High-Strength Wastewater and Waste-to-Energy (HSWW), SEA & China, Ivory Coast project (IVC), and Build-Own-Operate (BOO) projects and O&M contracts for equipment sales. The DMWW segment includes MABR (Aspiral, SUBRE and Nitro), and Nirobox products. The SIW segment focuses on water reuse applications and high-growth markets such as lithium mining, which supports the trend toward electrification. The HSWW segment is providing solutions that support the shift to global decarbonization.

πŸ“ˆ Performance

Price History

-79.33%

1M

1Y

10Y

Graph

Table

Unsure how much or often to invest?
πŸ—“οΈ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out β†’
πŸ’΅ Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out β†’
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out β†’

πŸ’΅ Costs

πŸ’΅

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

πŸ’Ό

N/A
Management Fee

Included in unit price, not charged by Pearler

πŸ’Έ

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
πŸ’Έ Net fee calculator

πŸ€“ Advanced information

Technical Info

πŸ’° Price*

$0.06

*Price may be up to 24 hours old

πŸ‘©β€πŸ‘©β€πŸ‘¦ Community Insights

How our community is investing

🌏 Pearlers invested in FLC

3

πŸ“Š Total Capital Earnings

N/A

πŸ”ƒ Average investment frequency

37 weeks

πŸ’΅ Average investment amount

$922

⏰ Last time a customer invested in FLC

150 days
FLC investor breakdown
πŸ’΅ Income of investors

More than 200k

40%

150k - 200k

100k - 150k

50k - 100k

Less than 50k

60%
πŸ‘Ά Age of investors

18 - 25

26 - 34

33%

35 - 90

67%
πŸ™‹ Legal gender of investors

Female

67%

Male

33%

Pearlers who invest in FLC also invest in...

Neuren Pharmaceuticals Limited

NEU

Neuren Pharmaceuticals Ltd. is a biopharmaceutical company, which engages in the development of new therapies for brain injury, neurodevelopment, and neurodegenerative disorders. The company is headquartered in Melbourne, Victoria. The company went IPO on 2005-02-03. The firm is developing new drug therapies to treat multiple serious neurological disorders that emerge in early childhood and have no or limited approved treatment options. The Company’s product DAYBUE (trofinetide) is used to treat Rett syndrome in adults and pediatric patients two years of age and older. The United States (US) Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have both granted orphan drug designation to the Company for trofinetide in Fragile X syndrome. Its second product NNZ-2591 is in phase II clinical trials in Phelan-McDermid syndrome, Angelman syndrome, Pitt Hopkins syndrome and Prader-Willi syndrome. The firm has granted an exclusive worldwide license to Acadia Pharmaceuticals Inc. for the development and commercialization of NNZ-259 for Rett syndrome and Fragile X syndrome.

πŸ™Œ Performance (5Yr p.a)

89.12%

πŸ“Š Share price

$13.04 AUD

πŸ“¦ LOGISTICS

Find Out More

VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.

πŸ™Œ Performance (5Yr p.a)

3.90%

πŸ“Š Share price

$102.07 AUD

πŸ‡¦πŸ‡Ί AUSTRALIA

πŸ’Έ FINANCIALS

🧱 MATERIALS

⛳️ DIVERSIFIED

Cleanaway Waste Management Ltd. engages in the provision of total waste management, industrial, and environment services. The company is headquartered in Melbourne, Victoria. The company went IPO on 2005-05-03. Its Solid Waste Services segment comprises the collection, recovery and disposal of all types of solid waste, including putrescible waste, inert waste, household waste and recovered waste. Its Industrial & Waste Services segment provides a variety of services to the resources, oil and gas, industrial and infrastructure markets. The services include high pressure cleaning, vacuum loading, pipeline maintenance, non-destructive digging, drain cleaning and CCTV. Its Liquid Waste & Health Services segment consists of Liquid Waste, which is engaged in the collection, treatment, processing, refining and recycling and destruction of hazardous and non-hazardous liquids, hydrocarbons and chemical waste, and others; and Health Services, which is engaged in the provision of services to the health sector for the safe treatment and disposal of health-related waste.

πŸ™Œ Performance (5Yr p.a)

2.54%

πŸ“Š Share price

$2.57 AUD

πŸ”¨ COMMERCIAL SERVICES & SUPPLIES

ESGI.AX was created on 2018-03-06 by VanEck. The fund's investment portfolio concentrates primarily on total market equity. The Fund aims to provide investment returns before fees and other costs which track the performance of its Reference Index in Australian dollars.

πŸ™Œ Performance (5Yr p.a)

9.05%

πŸ“Š Share price

$37.03 AUD

πŸ“ˆ HIGH PRICE GROWTH

πŸ€– TECHNOLOGY

🌏 GLOBAL

IMPQ.AX was created on 2021-09-29 by Perennial. The fund's investment portfolio concentrates primarily on total market equity. The objective of the Fund is to deliver long-term capital growth predominately through investments in Australian and New Zealand listed smaller and mid-cap companies that are Better Future Investments.

πŸ™Œ Performance (5Yr p.a)

1.95%

πŸ“Š Share price

$4.85 AUD

Want more shares? Try these...

FLCAAD

πŸ“Š Share price

$0.03 AUD
Compare
Add to watchlist